These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8395 related articles for article (PubMed ID: 2160258)

  • 1. Regulation of cell growth by recombinant oncostatin M.
    Horn D; Fitzpatrick WC; Gompper PT; Ochs V; Bolton-Hansen M; Zarling J; Malik N; Todaro GJ; Linsley PS
    Growth Factors; 1990; 2(2-3):157-65. PubMed ID: 2160258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of cellular receptors for the growth regulator, oncostatin M.
    Linsley PS; Bolton-Hanson M; Horn D; Malik N; Kallestad JC; Ochs V; Zarling JM; Shoyab M
    J Biol Chem; 1989 Mar; 264(8):4282-9. PubMed ID: 2538434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
    Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncostatin M-mediated growth inhibition of human glioblastoma cells does not depend on stat3 or on mitogen-activated protein kinase activation.
    Halfter H; Stögbauer F; Friedrich M; Serve S; Serve H; Ringelstein EB
    J Neurochem; 2000 Sep; 75(3):973-81. PubMed ID: 10936178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
    Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG; Hoggatt IH; Rose TM
    J Immunol; 1992 Aug; 149(4):1271-5. PubMed ID: 1380037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
    McDonald VL; Dick KO; Malik N; Shoyab M
    Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
    Brown TJ; Lioubin MN; Marquardt H
    J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abrogation of the antiproliferative activity of oncostatin M by a monoclonal antibody.
    Radka SF; Naemura JR; Shoyab M
    Cytokine; 1992 May; 4(3):221-6. PubMed ID: 1379836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
    Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
    Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.
    Zarling JM; Shoyab M; Marquardt H; Hanson MB; Lioubin MN; Todaro GJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9739-43. PubMed ID: 3540948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M induces the differentiation of breast cancer cells.
    Douglas AM; Grant SL; Goss GA; Clouston DR; Sutherland RL; Begley CG
    Int J Cancer; 1998 Jan; 75(1):64-73. PubMed ID: 9426692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism.
    Grove RI; Mazzucco CE; Radka SF; Shoyab M; Kiener PA
    J Biol Chem; 1991 Sep; 266(27):18194-9. PubMed ID: 1655740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of oncostatin M in plasmacytoma development.
    Barton BE; Jackson JV; Lee F; Wagner J
    Cytokine; 1994 Mar; 6(2):147-53. PubMed ID: 8031997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
    Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
    J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells.
    Miles SA; Martínez-Maza O; Rezai A; Magpantay L; Kishimoto T; Nakamura S; Radka SF; Linsley PS
    Science; 1992 Mar; 255(5050):1432-4. PubMed ID: 1542793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
    Lu C; Rak JW; Kobayashi H; Kerbel RS
    Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncostatin M regulation of interleukin-6 expression in astrocytes: biphasic regulation involving the mitogen-activated protein kinases ERK1/2 and p38.
    Van Wagoner NJ; Choi C; Repovic P; Benveniste EN
    J Neurochem; 2000 Aug; 75(2):563-75. PubMed ID: 10899931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 420.